Identification and Function of Cyclic Nucleotide Phosphodiesterase Isoenzymes in Airway Epithelial Cells

1999 ◽  
Vol 20 (2) ◽  
pp. 292-302 ◽  
Author(s):  
Martin Fuhrmann ◽  
Hans-Ulrich Jahn ◽  
Joachim Seybold ◽  
Claus Neurohr ◽  
Peter J. Barnes ◽  
...  
2021 ◽  
pp. 2100671
Author(s):  
Frédéric Becq ◽  
Sandra Mirval ◽  
Thomas Carrez ◽  
Manuella Lévêque ◽  
Arnaud Billet ◽  
...  

Trikafta, currently the leading therapeutic in Cystic Fibrosis (CF), has demonstrated a real clinical benefit. This treatment is the triple combination therapy of two folding correctors elexacaftor/tezacaftor (VX445/VX661) plus the gating potentiator ivacaftor (VX770). In this study, our aim was to compare the properties of F508del-CFTR in cells treated with either lumacaftor (VX809), tezacaftor, elexacaftor, elexacaftor/tezacaftor with or without ivacaftor. We studied F508del-CFTR function, maturation and membrane localisation by Ussing chamber and whole-cell patch clamp recordings, Western blot and immunolocalization experiments. With human primary airway epithelial cells and the cell lines CFBE and BHK expressing F508del, we found that, whereas the combination elexacaftor/tezacaftor/ivacaftor was efficient in rescuing F508del-CFTR abnormal maturation, apical membrane location and function, the presence of ivacaftor limits these effects. The basal F508del-CFTR short-circuit current was significantly increased by elexacaftor/tezacaftor/ivacaftor and elexacaftor/tezacaftor compared to other correctors and non-treated cells, an effect dependent on ivacaftor and cAMP. These results suggest that the level of the basal F508del-CFTR current might be a marker for correction efficacy in CF cells. When cells were treated with ivacaftor combined to any correctors, the F508del-CFTR current was unresponsive to the subsequently acute addition of ivacaftor unlike the CFTR potentiators genistein and Cact-A1 which increased elexacaftor/tezacaftor/ivacaftor and elexacaftor/tezacaftor-corrected F508del-CFTR currents. These findings show that ivacaftor reduces the correction efficacy of Trikafta. Thus, combining elexacaftor/tezacaftor with a different potentiator might improve the therapeutic efficacy for treating CF patients.


2009 ◽  
Vol 229 (2) ◽  
pp. 101-113 ◽  
Author(s):  
Tamene Melkamu ◽  
Diane Squillace ◽  
Hirohito Kita ◽  
Scott M. O’Grady

2010 ◽  
Vol 299 (5) ◽  
pp. L681-L693 ◽  
Author(s):  
Steven R. White ◽  
Linda D. Martin ◽  
Randi Stern ◽  
Bharathi Laxman ◽  
Bertha A. Marroquin

IL-4 and IL-13 elicit several important responses in airway epithelium including chemokine secretion and mucous secretion that may contribute to airway inflammation, cell migration, and differentiation. These cytokines have overlapping but not identical effector profiles likely due to shared subunits in their receptor complexes. These receptors are variably described in epithelial cells, and the relative expression, localization, and function of these receptors in differentiated and repairing epithelial cells are not clear. We examined IL-4/IL-13 receptor expression and localization in primary airway epithelial cells collected from normal human lungs and grown under conditions yielding both undifferentiated and differentiated cells inclusive of basal, goblet, and ciliated cell phenotypes. Gene expression of the IL-4Rα, IL-2Rγc, IL-13Rα1, and IL-13Rα2 receptor subunits increased with differentiation, but different patterns of localization and protein abundance were seen for each subunit based on both differentiation and the cell subtypes present. Increased expression of receptor subunits observed in more differentiated cells was associated with more substantial functional responses to IL-4 stimulation including increased eotaxin-3 expression and accelerated migration after injury. We demonstrate substantial differences in IL-4/IL-13 receptor subunit expression and responsiveness to IL-4 based on the extent of airway epithelial cell differentiation and suggest that these differences may have functional consequences in airway inflammation.


2017 ◽  
Vol 4 (S) ◽  
pp. 41 ◽  
Author(s):  
Badrul Hisham Yahaya

Endogenous repair mechanism of airway epithelial cells often fails to achieve sufficient cellular turnover and diminish with age, thus leading to permanent alterations in the structure and function of the airway epithelium. The therapeutic use of stem cells and progenitor cells represents a promising alternative for clinical strategy in treating acute and chronic lung disorders. Aerosol-based cell therapy is a novel therapeutic strategy in enhancing reparative process following both acute and chronic lung injuries. In such background, this study was aimed to determine the effect of aerosol-based cell delivery using MicroSprayer® Aerosolizer in the setting of acute lung injury (ALI) and ovalbumin-induced airway injury in the rabbit. In vitro evaluation revealed that the aerosol technique didn’t cause a significant effect on cell morphology, viability and proliferation capability over the course of cell culture period. Aerosol delivery of airway epithelial cells (AEC) and mesenchymal stem cell (MSC) resulted in uniform distribution in the distal airway and lung interstitial region. Short term assessment showed that cells delivered to the lungs via aerosol was found to be safe for transplantation with no signs of cell rejection and histopathological alterations in the liver and spleen of all treated animals. Histological evidences also demonstrated that administration of AEC and MSC via aerosolization into the respiratory airway prevented lung inflammation as well as resulted in improvement of both alveolar damage and permeability. To our knowledge, this is the first report of aerosol cell delivery via a Microsprayer® Aerosolizer device to the lungs of rabbits to treat airway injuries. Our findings provide a promising evidence that aerosol-based cell therapy may provide a basis for the development of an innovative approach for the treatment lung injuries.


2009 ◽  
Vol 23 (S1) ◽  
Author(s):  
Cara L. Sherwood ◽  
Andrew E. Liguori ◽  
Colin E. Olsen ◽  
R. Clark Lantz ◽  
Jefferey L. Burgess ◽  
...  

2013 ◽  
Vol 14 (1) ◽  
pp. 97 ◽  
Author(s):  
Roland F Hoffmann ◽  
Sina Zarrintan ◽  
Simone M Brandenburg ◽  
Arjan Kol ◽  
Harold G de Bruin ◽  
...  

1995 ◽  
Vol 268 (6) ◽  
pp. C1520-C1527 ◽  
Author(s):  
D. E. McCoy ◽  
E. M. Schwiebert ◽  
K. H. Karlson ◽  
W. S. Spielman ◽  
B. A. Stanton

A role for adenosine in the regulation of ion transport in pulmonary epithelial cells has recently been proposed. Although evidence exists documenting the presence and function of adenosine A2 receptors in airway epithelia, the presence of adenosine A1 receptors remains controversial. The present study used reverse transcriptase-polymerase chain reaction (PCR) and whole cell patch-clamp analysis to investigate A1 receptor presence and function in normal and cystic fibrosis (CF) human airway epithelial cells. Oligonucleotide primers complementary to the human brain A1 receptor sequence generated a PCR product of the predicted size (311 bp) in normal tracheal (9HTEo-) and CF submucosal (2CFSMEo-) airway cell lines and in primary cultures of CF nasal polyp epithelial cells. An oligonucleotide probe internal to the PCR primers hybridized with the 311-bp cDNAs by Southern blot analysis. cDNA sequencing demonstrated that the normal and CF airway cell PCR products are 100% identical to the corresponding sequence of the human brain adenosine A1 receptor. Northern blot analysis of 9HTEo-and 2CFSMEo- poly(A)+ RNA revealed the presence of two bands of approximately 3.0 and approximately 5.5 kb corresponding to the A1 receptor. Whole cell patch-clamp analyses demonstrated that 8-cyclopentyl-1,3-dipropylxanthine, a specific A1 receptor antagonist, increases adenosine 3',5'-cyclic monophosphate (cAMP)-activated Cl- conductance in 9HTEo-airway cells and allows cAMP to increase Cl- conductance in 2CFSMEo- CF airway cells and CF nasal polyp epithelial cells in primary culture. These results provide evidence for the presence and function of A1 receptors in normal and CF airway epithelial cells and provide support for a role of adenosine A1 receptors in modulating airway epithelial cell Cl- transport.


2021 ◽  
Vol 77 ◽  
pp. 105253
Author(s):  
Jenny P. Nguyen ◽  
Ryan D. Huff ◽  
Quynh T. Cao ◽  
Nicholas Tiessen ◽  
Christopher Carlsten ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document